Immune Thrombocytopenia Clinical Trials in Shanghai, Shanghai Municipality
6 recruitingShanghai, Shanghai Municipality, China
Showing 1–6 of 6 trials
Recruiting
Early Phase 1
An Exploratory Study of CD19/CD22/BCMA CAR-T Cells (BZE2204) in Subjects With Relapsed or Refractory Autoimmune Diseases
Systemic Lupus Erythematosus (SLE)Immune Thrombocytopenia (ITP)Idiopathic Inflammatory Myopathies(IIM)
Shanghai Cell Therapy Group Co.,Ltd20 enrolled1 locationNCT07174843
Recruiting
Phase 3
A Study of TQB3473 Tablets Compared to Placebo in the Treatment of Adult Primary Immune Thrombocytopenia
Primary immune thrombocytopenia
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.199 enrolled53 locationsNCT06900920
Recruiting
Not Applicable
The Efficacy and Safety of HCQ Plus DEX in ANA Positive ITP
Immune Thrombocytopenia With Positive ANA Antibodies
Yunfeng Cheng129 enrolled7 locationsNCT06479317
Recruiting
Not Applicable
The Efficacy and Safety of HCQ Plus Pred in ANA Positive ITP
Immune Thrombocytopenia With Positive ANA Antibodies
Yunfeng Cheng129 enrolled7 locationsNCT06479304
Recruiting
Not Applicable
The Efficacy and Safety of HCQ Plus TPO-RA in ANA Positive ITP
Immune Thrombocytopenia With Positive ANA Antibodies
Yunfeng Cheng126 enrolled7 locationsNCT06479291
Recruiting
Phase 3
Evaluate the Efficacy and Safety of Orelabrutinib in Adult Patients With Chronic Primary Immune Thrombocytopenia
Chronic Primary Immune Thrombocytopenia (ITP)
Beijing InnoCare Pharma Tech Co., Ltd.195 enrolled45 locationsNCT06004856